Joseph B. Birchansky

Internal Medicine
40 Catherwood Rd Ste R
Ithaca, NY 14850

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Milvexian: A Focus on a New Oral Anticoagulant that Targets Factor XIa for Thromboembolism Prophylaxis.

Milvexian: A Focus on a New Oral Anticoagulant that Targets Factor XIa for Thromboembolism Prophylaxis.

Journal: Cardiology in review
Published: February 02, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026